Domesco Medical Import Export Joint Stock Corp
VN:DMC
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EV/EBITDA
Enterprise Value to EBITDA (EV/EBITDA) ratio compares a company`s total enterprise value to its earnings before interest, taxes, depreciation, and amortization. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Enterprise Value to EBITDA (EV/EBITDA) ratio compares a company`s total enterprise value to its earnings before interest, taxes, depreciation, and amortization. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Valuation Scenarios
If EV/EBITDA returns to its 3-Year Average (7.1), the stock would be worth ₫65 450.76 (9% upside from current price).
| Scenario | EV/EBITDA Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 6.5 | ₫60 000 |
0%
|
| 3-Year Average | 7.1 | ₫65 450.76 |
+9%
|
| 5-Year Average | 6.7 | ₫62 003.24 |
+3%
|
| Industry Average | 12 | ₫110 598.14 |
+84%
|
| Country Average | 10.5 | ₫96 394.09 |
+61%
|
Forward EV/EBITDA
Today’s price vs future ebitda
Peer Comparison
| Market Cap | EV/EBITDA | P/E | ||||
|---|---|---|---|---|---|---|
| VN |
D
|
Domesco Medical Import Export Joint Stock Corp
VN:DMC
|
2.1T VND | 6.5 | 12.4 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
869.1B USD | 28 | 41.3 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
555.5B USD | 16.6 | 25.9 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF | 11.7 | 19.8 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
225.8B GBP | 16.2 | 29.2 | |
| CH |
|
Novartis AG
SIX:NOVN
|
226.8B CHF | 12.3 | 19.9 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
289.8B USD | 9.5 | 15.3 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
244.4B USD | 386.8 | -83.6 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK | 8 | 10.9 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
156.5B USD | 7.7 | 20 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
119.6B USD | 7.2 | 17 |
Market Distribution
| Min | 0.1 |
| 30th Percentile | 6.9 |
| Median | 10.5 |
| 70th Percentile | 15.8 |
| Max | 3 893.3 |
Other Multiples
Domesco Medical Import Export Joint Stock Corp
Glance View
Domesco Medical Import Export JSC engages in the manufacture, trade, and market of pharmaceutical products. The company is headquartered in Cao Lanh, Dong Thap and currently employs 990 full-time employees. The company went IPO on 2006-04-12. Its principal activities include manufacturing, marketing and importing pharmaceutical products and materials for the manufacture of medicine for human, medical equipment, experimental chemicals, drinking water, mineral water and drinking water from medicine, wine, functional food and nutritious food. The firm is also active in the plantation of medical materials, as well as the manufacture, marketing, import and export of feed for poultry, cattle and aquatic animals, along with materials for the manufacture of animal feed. The firm has one subsidiary involved in the import, export and marketing of basic chemicals and other chemicals used in the production of industrial alcohol.
